Gastric Cancer

1,810 clinical trials · Condition

Record	Firm	Date
D1 vs D2 Lymphadenectomy in Gastric Cancer (NCT05253430)	Fundación para la Investigación del Hospital Clínico de Valencia	1990-04-01
Phase I Study of Sorafinib With Folfox4 as First-line Treatment in Advanced/Metastatic Gastric Cancer (NCT02209441)	Chinese Academy of Medical Sciences
Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients (NCT05974410)	AVM Biotechnology Inc
A Study of ARQ 197 Versus Investigator's Choice of Second-Line Chemotherapy in Patients With Locally Advanced or Metastatic Gastric Cancer Who Have Progressive Neoplastic Disease Following Treatment With One Prior Chemotherapy Regimen (NCT01070290)	ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in France (NCT02307812)	Eli Lilly and Company
Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors (NCT04681248)	Leap Therapeutics, Inc.
SU006668 in Treating Patients With Advanced Solid Tumors (NCT00024063)	Jonsson Comprehensive Cancer Center
Efficacy Study of Paclitaxel Versus Irinotecan in Patients With Recurrent or Metastatic Gastric Cancer Who Progress Following First-line Therapy (NCT01224652)	Korean Cancer Study Group
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies (NCT04566393)	xCures
Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour Surgery (NCT02446379)	Lightpoint Medical Limited

Track Gastric Cancer automatically

Every clearance here is in the API, with alerts when new ones post.